Page 1 of Clinical Trials for Unresectable Stage IV Non Small-cell Lung Cancer NSCLC, 86 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Non-small Cell Lung Cancer Registry
Last Updated: November 20, 2009
Condition(s): Non-Small-Cell Lung Cancer; Pleural Effusion, Malignant
2
Active, not recruiting
Docetaxel and Carboplatin With or Without Zoledronate in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Last Updated: July 23, 2008
Condition(s): Lung Cancer
3
Active, not recruiting
Two Regimens of Docetaxel in Treating Patients Who Have Not Received Chemotherapy For Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Last Updated: February 10, 2011
Condition(s): Lung Cancer
4
Completed
Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab
Last Updated: May 9, 2009
Condition(s): Drug/Agent Toxicity by Tissue/Organ; Hemoptysis; Lung Cancer
5
Active, not recruiting
S-1 as Second-Line Therapy in Treating Patients With Unresectable or Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
Last Updated: October 30, 2010
Condition(s): Lung Cancer
6
Terminated
Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer
Last Updated: May 19, 2011
Condition(s): Lung Cancer
7
Active, not recruiting
ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer or Unresectable or Metastatic Melanoma
Last Updated: February 6, 2009
Condition(s): Lung Cancer; Melanoma (Skin)
8
Active, not recruiting
Hospitalization Rates of Patients With Non-Small Cell Lung Cancer Treated With Gemcitabine and Either Cisplatin or Carboplatin
Last Updated: January 24, 2009
Condition(s): Lung Cancer
9
Active, not recruiting
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors
Last Updated: March 5, 2012
Condition(s): Extensive Stage Small Cell Lung Cancer; Hereditary Paraganglioma; Male Breast Cancer; Malignant Paraganglioma; Metastatic Gastrointestinal Carcinoid Tumor; Metastatic Pheochromocytoma; Pancreatic Polypeptide Tumor; Recurrent Breast Cancer; Recurrent Cervical Cancer; Recurrent Endometrial Carcinoma; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; Recurrent Neuroendocrine Carcinoma of the Skin; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Pheochromocytoma; Recurrent Prostate Cancer; Recurrent Renal Cell Cancer; Recurrent Small Cell Lung Cancer; Recurrent Uterine Sarcoma; Regional Gastrointestinal Carcinoid Tumor; Regional Pheochromocytoma; Stage III Cervical Cancer; Stage III Endometrial Carcinoma; Stage III Neuroendocrine Carcinoma of the Skin; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Prostate Cancer; Stage III Renal Cell Cancer; Stage III Uterine Sarcoma; Stage IIIA Breast Cancer; Stage IIIA Non-small Cell Lung Cancer; Stage IIIB Breast Cancer; Stage IIIB Non-small Cell Lung Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer; Stage IV Endometrial Carcinoma; Stage IV Neuroendocrine Carcinoma of the Skin; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Prostate Cancer; Stage IV Renal Cell Cancer; Stage IV Uterine Sarcoma; Stage IVA Cervical Cancer; Stage IVB Cervical Cancer; Thyroid Gland Medullary Carcinoma
10
Completed
Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
Last Updated: February 26, 2011
Condition(s): Lung Cancer
11
Terminated
A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
Last Updated: September 29, 2011
Condition(s): Carcinoma, Non-Small-Cell Lung
12
Completed
GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors
Last Updated: December 15, 2009
Condition(s): Lung Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific
13
Completed
Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment
Last Updated: August 5, 2010
Condition(s): Lung Cancer
14
Completed
Carboplatin and Paclitaxel in Treating Older Patients With Metastatic or Recurrent Unresectable Non-Small Cell Lung Cancer
Last Updated: February 6, 2009
Condition(s): Lung Cancer
15
Completed
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Last Updated: April 27, 2012
Condition(s): Non-small Cell Lung Cancer
16
Terminated
S0322, Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
Last Updated: August 24, 2011
Condition(s): Head and Neck Cancer; Lung Cancer
17
Completed
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Last Updated: September 22, 2010
Condition(s): Anorexia; Cachexia; Fatigue; Lung Cancer
18
Completed
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
Last Updated: March 30, 2012
Condition(s): Lung Cancer
19
Completed
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer
Last Updated: February 6, 2009
Condition(s): Colorectal Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Pancreatic Cancer
20
Recruiting
Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Last Updated: August 19, 2011
Condition(s): Bladder Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Lung Cancer; Pancreatic Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Unresectable+Stage+IV+Non+Small-cell+Lung+Cancer+NSCLC

Page 1 of Clinical Trials for Unresectable Stage IV Non Small-cell Lung Cancer NSCLC, 86 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About